Quick answer
Building a sales team for a biotech company is less about hiring closers and more about hiring credibility. Your buyers are scientists who evaluate on data and reproducibility, so the people who sell to them need enough technical fluency to be taken seriously by a principal investigator. Start founder-led while you learn what resonates, hire first for domain credibility rather than pure closing skill, and structure the team for long, research-driven cycles and a multi-person lab committee. The general playbook applies; the difference is how much scientific trust each role has to carry.
Why a biotech sales team is different
In most B2B markets you can hire a strong generalist seller and teach them the product. In biotech that order often fails, because the buyer can tell within a sentence whether the person across from them understands the science.
Principal investigators and end-user scientists evaluate on evidence. A rep who cannot discuss the data honestly, or who reaches for marketing language when pressed on a technical point, loses credibility and the deal with it. So the central hiring question in biotech is not "can this person close?" but "will a data-driven buyer trust this person?" The general team-building principles are in how to build a sales team; this article adapts them for the scientific buyers described on our biotech go-to-market page.
How long should a biotech company stay founder-led?
Longer than most, and for a specific reason. In an early biotech company the founder is usually the most scientifically credible person in the building, which is exactly what the buyer wants to talk to.
Founder-led selling is how you learn which parts of the science resonate, which objections recur, and how the grant-driven buying process actually unfolds. Do not hand that off until the motion is repeatable: you can predict why a lab says yes, how long the cycle runs, and where funding gates sit. The risk of hiring too early is handing a half-understood, credibility-heavy sale to someone who cannot yet carry it. For the general timing, see who should be your first sales hire.
Who should the first sales hire be?
In biotech, the first commercial hire usually needs to carry technical credibility, not just pipeline discipline. The two common profiles:
- A scientist who can sell. Someone with a research background who can hold a peer-level conversation with a PI and genuinely enjoys the commercial side. The strength is instant credibility; the risk is unproven selling instinct.
- A seller with real life-sciences experience. Someone who has sold into labs or research institutions before and understands grant cycles and procurement. The strength is a proven motion; the risk is depth of science.
Either can work. What does not work is a generalist with neither science nor sector experience, because they cannot earn trust with the buyer or navigate the funding-driven cycle. Match the depth of science required to how technical your buyer is: a benchtop research tool demands more scientific fluency than a back-office lab product. See who should be your first sales hire for the general decision.
How do SDR, BDR and AE roles map to biotech?
The standard split still applies, but the credibility bar changes what each role can own.
| Role | Typical job | Biotech adjustment |
|---|---|---|
| SDR / BDR | Prospect and book meetings | Can open the right labs, but technical replies often need a credible escalation |
| AE | Run and close deals | Must hold a data-level conversation and manage a long, multi-stakeholder cycle |
| Sales / technical lead | Own the motion | Carries the scientific narrative and trains the team on it |
The practical implication: a junior SDR can research labs, personalize at the segment level and open conversations, but a scientific buyer who engages will quickly want a credible technical counterpart. Design the handoff so a researcher's real question reaches someone who can answer it, fast. The general role definitions are in SDR vs BDR vs AE.
How do you structure the team for long cycles?
Biotech cycles run for months on grant timing and involve a six-to-ten-person buying group, which changes how you staff and measure. Gartner has found the typical B2B buying group involves six to ten decision makers, and life-sciences deals sit at the higher end.
Three structural choices matter:
- Fewer, more capable people early. A long, credibility-heavy cycle rewards a small senior team over a large junior one.
- Clear account ownership. One person must hold the full lab committee and the funding timeline across months, or deals go silent between meetings.
- Metrics tuned for the cycle. Judge the team on pipeline created and stage conversion, not on activity, because activity in a slow market tells you little. This connects directly to how to build a sales pipeline for biotech.
What should you document before you hire?
Because credibility in biotech is personal, the handoff from founder to team is where momentum is usually lost. The fix is to write down what lives in the founder's head before the first hire starts.
Capture the technical narrative (why the science matters, the proof points that land, the honest answers to hard questions), the ideal lab profile, the real buying process including funding gates, and the objections you have already seen. That documentation is what lets a capable hire carry a credibility-heavy sale instead of relearning it deal by deal. It is also the backbone of the go-to-market system covered in GTM strategy for biotech startups.
Where Enablemnt fits
Building a biotech sales team is a real commitment: the right credible hires, a documented technical narrative, a structure for long cycles, and the infrastructure for them to sell on. Most early-stage companies are not ready to carry those salaries while they are still proving the motion.
Enablemnt is a way to run the revenue motion before you build the team, or to hand the team a working system when you do. As your embedded RevOps and outbound group, we build the full go-to-market engine in a fixed 14-day sprint: the target list of the right labs, a CRM for long research cycles, and live, technically credible outreach. You learn what resonates with real pipeline, and when you hire, you hand your team a documented, working system instead of a blank slate. You own all of it.
If you want the motion running and documented before you commit to headcount, tell us about your company and we will map your GTM blueprint on a short call.
Follow Enablemnt AI on LinkedInShort, practical posts on GTM, outbound and RevOps for early-stage B2B founders.FollowFrequently asked questions
- Who should a biotech company hire first for sales?
- Usually someone who can hold a credible technical conversation with scientists, not a generalist closer. Because biotech buyers evaluate on data and reproducibility, a first commercial hire with domain fluency, often a scientist who can sell or a seller with real life-sciences experience, earns trust that a generic rep cannot. The exact profile depends on your product and how technical the buyer is.
- Do biotech sales reps need a science background?
- They need enough scientific credibility to be taken seriously by a principal investigator, which often but not always means a formal background. What matters is the ability to discuss the data honestly and accurately; a seller who can learn the science deeply can work, while one who papers over technical questions will lose a data-driven buyer fast.
- When should a biotech startup build a sales team versus stay founder-led?
- Stay founder-led while the founder, often the most credible scientific voice, is still learning what resonates and closing the first deals. Build the team once the motion is repeatable and founder time is the bottleneck. In biotech the handoff is harder because credibility is personal, so document the technical narrative before you hire.
Keep reading
- Go-to-market (GTM) strategy for biotech startupsA practical GTM strategy for biotech startups: targeting the right labs, evidence-led messaging, grant-cycle timing, and the infrastructure to run it.
- How to build a sales pipeline for a biotech companyHow to build a sales pipeline for a biotech company: stages for scientific buyers, lab procurement and grant cycles, plus the CRM and forecast to run it.
- How to build a sales team for a B2B startupHow to build a sales team for a B2B startup: when to hire, who to hire first, how to structure and ramp the team, comp basics, and the mistakes to avoid.
- Who should be your first sales hire?Who your first sales hire should be: full-cycle rep, SDR, or AE, how to decide based on where your funnel breaks, and why the system matters more than the title.
Filed under By industry. Written by Enablemnt AI.
